Skip to content

Branchlab

4 viewers · 30d

Total raised

$28.8M

+$28.8M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $28.8M
ROUNDS
1
INVESTORS
27
FOUNDED
N/A
HQ
New York, NY
SECTOR
Media
EMPLOYEES
N/A
30D VIEWERS
4

AI overview

Updated

BranchLab is a New York data science company that builds AI-driven advertising and audience activation software for healthcare and pharmaceutical marketing. Its platform, Pathwai, models patient, caregiver and healthcare-provider audiences using non-health demographic and behavioral signals rather than protected health information, so campaigns can be targeted without touching PHI. Advertisers can build and refine audiences, activate them across omnichannel media, and measure real-world outcomes such as prescriptions, diagnoses and healthcare visits. The company was founded in 2024 by Josh Walsh, Michael Parkes and Chris Cagle, and reports use by leading pharmaceutical brands.

What sets it apart

An ID-less, PHI-free approach that reaches predictive targeting performance from non-health data, which BranchLab reports as roughly 3x the performance of claims-based methods at far lower cost while sidestepping the privacy constraints that slow healthcare advertising.

Funding history

1 round
EquityMay 4, 2026
Form D
+$28.8M$28.8M total

Latest SEC filings

via EDGAR · CIK 0002017708
Form D · May 4, 2026View on EDGAR

Products

1 tracked

Pathwai

Healthcare adtech / audience activation platform

A unified AI platform for healthcare commercialization that designs, activates and measures advertising audiences optimized to real-world health outcomes, built entirely on non-PHI data.

  • Audience exploration across patient, HCP and caregiver segments without PHI
  • AI-driven audience development and refinement
  • Omnichannel activation across media channels and platforms
  • Outcomes measurement against prescriptions, diagnoses and healthcare visits